1.Effects of keto acid supplements on Chinese patients receiving maintenance hemodialysis: a prospective, randomized, controlled,single-center clinical study
Li HAI-LONG ; Li HUI ; Cao YI-FU ; Qi YUE ; Wang WEI-QI ; Liu SHI-QIN ; Yang CHEN-DIE ; Yu XIAO-YAN ; Xu TAO ; Zhu YAN ; Chen WEI ; Tao JIAN-LING ; Li XUE-WANG
Chinese Medical Journal 2020;133(1):9-16
Background:The effects of keto acid (KA) supplements on Chinese patients receiving maintenance hemodialysis (MHD) are unclear.This study aimed to evaluate the effects of KA supplementation on nutritional status,inflammatory markers,and bioelectric impedance analysis (BIA) parameters in a cohort of Chinese patents with MHD without malnutrition.Methods:This was a prospective,randomized,controlled,single-center clinical study conducted in 2011 till 2014.Twenty-nine patients with MHD were randomly assigned to a control (n =14) or a KA (n =15) group.The control group maintained a dietary protein intake of 0.9 g/kg/day.The KA group received additional KA supplement (0.1 g/kg/day).BIA was used to determine the lean tissue mass,adipose tissue mass,and body cell mass.The patients' nutritional status,dialysis adequacy,and biochemical parameters were assessed at the ends of the third and sixth months with t test or Wilcoxon rank-sum test.Results:The daily total energy intake for both groups was about 28 kcal/kg/day.After 6 months,the Kt/V (where K is the dialyzer clearance of urea,t is the dialysis time,and V is the volume of the distribution of urea) was 1.33 ± 0.25 in KA group,and 1.34 ± 0.25in the control group.The median triceps skin-fold thickness in KA group was 12.00 and 9.00 mm in the control group.In addition,the median hand-grip strength in KA group was 21.10 and 25.65 kg in the control group.There were no significant differences between the groups with respect to the anthropometry parameters,dialysis adequacy,serum calcium and phosphorus levels,inflammatory markers,and amino-acid profiles,or in relation to the parameters determined by BIA.Both groups achieved dialysis adequacy and maintained nutritional status during the study.Conclusions:In this cohort of Chinese patients with MHD,the patients in the control group whose dietary protein intake was 0.9 g/ kg/day and total energy intake was 28 kcal/kg/day,maintained well nutritional status during study period.The KA supplement (0.1 g/kg/day) did not improve the essential amino acid/non-essential amino acid ratio,nor did it change the patients' mineral metabolism,inflammatory parameters,or body compositions.
2.Clinical analysis of the therapeutic effect of allogeneic hematopoietic stem cell transplantation in 10 cases of childhood myelodysplastic syndrome/myeloproliferative neoplasm.
Yi Na SUN ; Shao Yan HU ; Hai Long HE ; Yi WANG ; Jie LI ; Jun LU ; Pei Fang XIAO ; Yan Hua YAO ; Jun Jie FAN ; Hui LV ; Jing LING ; Die Xin HU ; De Pei WU
Chinese Journal of Hematology 2018;39(2):162-164
3.Status and Progress of Research on Metabolomics of Cervical Cancer
Shaojun CHEN ; Ling GAN ; Xinkang CHEN ; Lingling XIONG ; Die LONG ; Lulu CHEN ; Mengzhuan WEI ; Li HUA ; Haixin HUANG
Cancer Research on Prevention and Treatment 2025;52(7):630-636
Cervical cancer is one of the most common gynecological malignant tumors in China. Given their lack of obviously early symptoms, more than half of patients with cervical cancer are diagnosed in the middle and late stages of this malignancy, resulting in poor prognosis. Finding new therapeutic targets is the current research direction. Metabolomics, as a new omics technology, is expected to provide new targets for tumor precision diagnosis and treatment through the analysis of the changes and potential mechanisms of metabolites in tumor occurrence and development by chromatography, mass spectrometry, and other technologies. Herein, we review the research methods of metabolomics; metabolic characteristics of cervical cancer; and progress of the research on metabolomics in cervical cancer diagnosis, curative effect prediction, and prognosis evaluation to provide new ideas for the precise diagnosis and treatment of cervical cancer.